Met Life Investment Management, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$17.63 - $21.74 $305,862 - $377,167	17,349 New	17,349 $342,000
Q2 2023 Apr 29, 2024	BUY	$10.44 - $16.48 $181,123 - $285,911	17,349 New	17,349 $244,000
Q2 2023 Aug 10, 2023	BUY	$10.44 - $16.48 $181,123 - $285,911	17,349 New	17,349 $244,000
Q1 2023 May 09, 2024	BUY	$10.7 - $15.79 $185,634 - $273,940	17,349 New	17,349 $187 Million
Q4 2022 Jun 14, 2023	BUY	$11.42 - $17.05 $198,125 - $295,800	17,349 New	17,349 $260 Million
Q3 2022 Jun 14, 2023	BUY	$9.76 - $13.41 $169,326 - $232,650	17,349 New	17,349 $223 Million
Q2 2022 Jun 20, 2023	BUY	$7.6 - $11.41 $131,852 - $197,952	17,349 New	17,349 $168 Million
Q1 2022 May 10, 2024	BUY	$9.3 - $12.37 $161,345 - $214,607	17,349 New	17,349 $172,000
Q1 2022 Jun 20, 2023	BUY	$9.3 - $12.37 $161,345 - $214,607	17,349 New	17,349 $172 Million
Q4 2021 Jun 21, 2023	BUY	$10.39 - $15.15 $115,193 - $167,968	11,087 New	11,087 $130 Million
Q3 2021 Jun 21, 2023	BUY	$11.39 - $16.23 $126,280 - $179,942	11,087 New	11,087 $126 Million
Q1 2021 May 17, 2024	SELL	$16.68 - $23.97 $104,450 - $150,100	-6,262 Reduced 36.09%	11,087 $205,000
Q1 2021 Jun 26, 2023	BUY	$16.68 - $23.97 $184,931 - $265,755	11,087 New	11,087 $205 Million
Q4 2020 Jun 22, 2023	BUY	$14.8 - $21.15 $181,892 - $259,933	12,290 New	12,290 $217 Million
Q3 2020 May 24, 2024	BUY	$15.21 - $25.53 $49,995 - $83,917	3,287 Added 36.51%	12,290 $188 Million
Q3 2020 Jun 26, 2023	BUY	$15.21 - $25.53 $186,930 - $313,763	12,290 New	12,290 $188 Million
Q2 2020 May 24, 2024	SELL	$15.08 - $26.0 $125,857 - $216,996	-8,346 Reduced 48.11%	9,003 $229 Million
Q2 2020 Jun 26, 2023	BUY	$15.08 - $26.0 $135,765 - $234,078	9,003 New	9,003 $229 Million
Q1 2020 Jul 12, 2023	BUY	$11.0 - $19.76 $78,012 - $140,137	7,092 New	7,092 $110 Million

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$30.2 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.04 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

98.1K
Shares

$1.95 Million
0.08% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$786,955
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$597,900
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account